3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Obesity
2
Neoplasms
2
Motor Activity
2
Feeding Behavior
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neuroendocrine Tumors
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Angina, Unstable
1
Interventions
fludarabine phosphate
38
Cyclophosphamide
37
Peripheral Blood Stem Cell Transplantation
32
Busulfan
28
Tacrolimus
26
Whole-Body Irradiation
20
Mycophenolic Acid
19
Methotrexate
17
Antilymphocyte Serum
17
ruxolitinib
16
fludarabine
14
Filgrastim
13
Cyclosporine
12
Melphalan
11
Radiotherapy
9
Etoposide
9
thymoglobulin
8
Psychiatric Rehabilitation
8
Prednisone
8
Methylprednisolone
8
Cytarabine
6
Cord Blood Stem Cell Transplantation
6
Thiotepa
5
Sirolimus
5
Imatinib Mesylate
5
Flow Cytometry
5
Azacitidine
5
Alemtuzumab
5
sargramostim
4
merphos
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Primary Myelofibrosis
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled